Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-14 Girolamo Todd C CLO, SVP of Corp Dev Shares withheld for taxes −2,158 $0.82 $2K 160,827
2022-01-14 Mazzo David J Chief Executive Officer Shares withheld for taxes −6,611 $0.82 $5K 631,065
2022-01-13 Girolamo Todd C CLO, SVP of Corp Dev Shares withheld for taxes −2,563 $0.81 $2K 162,985
2022-01-13 Mazzo David J Chief Executive Officer Shares withheld for taxes −6,471 $0.81 $5K 637,676
2022-01-11 Girolamo Todd C CLO, SVP of Corp Dev Shares withheld for taxes −4,722 $0.87 $4K 165,548
2022-01-11 Mazzo David J Chief Executive Officer Shares withheld for taxes −16,740 $0.87 $14K 644,147
2022-01-10 Girolamo Todd C CLO, SVP of Corp Dev Grant or award +129,000 187,675
2022-01-10 Girolamo Todd C CLO, SVP of Corp Dev Shares withheld for taxes −17,405 $0.92 $16K 170,270
2022-01-10 Girolamo Todd C CLO, SVP of Corp Dev Grant or award · Stock Option (Right to Buy) +65,000 65,000
2022-01-10 Buck Kristen K EVP, R&D and CMO Grant or award +64,500 326,897
2022-01-10 Buck Kristen K EVP, R&D and CMO Shares withheld for taxes −7,694 $0.92 $7K 319,203
2022-01-10 Buck Kristen K EVP, R&D and CMO Grant or award · Stock Option (Right to Buy) +32,500 32,500
2022-01-10 Flowers Cynthia Louise Director Grant or award +65,430 145,847
2022-01-10 Whitaker Anne Clem Director Grant or award +65,430 182,635
2022-01-10 Davidson Michael H. Director Grant or award +65,430 209,753
2022-01-10 BROWN GREGORY B Director Grant or award +65,430 149,040
2022-01-10 Mazzo David J Chief Executive Officer Grant or award +401,000 717,297
2022-01-10 Mazzo David J Chief Executive Officer Shares withheld for taxes −56,410 $0.92 $52K 660,887
2022-01-10 Mazzo David J Chief Executive Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2022-01-10 TRABER PETER G Director Grant or award +65,430 149,190

Page 6 of 18 · 345 trades